SNPs at the 3′ End of the Angiotensinogen Gene Define Two Haplotypes Associated with the Common 235Met Variant  by Plummer, S. et al.
443
Letter to the Editor
Table 1
Frequency of SNPs and Standardized Linkage-Disequilibrium Coefficients
SNP
FREQUENCY
(np 192
Chromosomes)
a′D p D/Dmax
235Thr 11535A 11608T 12058A 12194C 12429T
Met235Thr .42 … … … … … …
C11535A .31 .803 … … … … …
C11608T .33 .667 1.000 … … … …
G12058A .06 .568 .733 .750 … … …
A12194C .06 .734 .754 .769 .911 … …
C12429T .07 .629 .771 .786 1.000 1.000 …
T12822C .39 .816 .829 .720 .863 .874 .766
a is the standardized coefficient of linkage disequilibrium; D is the classical coefficient of′D
linkage disequilibrium; and is the maximum D value that is possible given the allele frequencies.Dmax
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SNPs at the 3′ End of the Angiotensinogen Gene
Define Two Haplotypes Associated with the Common
235Met Variant
To the Editor:
Nakajima et al. (2002) have provided a valuable SNP-
based haplotype map of the angiotensinogen gene, AGT
(MIM 106150), in both Japanese and white American
populations. Several linkage and association studies have
supported the hypothesis that angiotensinogen plays a
role in the pathogenesis of essential hypertension (MIM
145500) and preeclampsia (MIM 189800) (Jeunemaitre
et al. 1992; Ward et al. 1993; Hata et al. 1994). An ex-
on 2 SNP that results in a Thr-Met polymorphism at
codon 235 has been associated with variation in plas-
ma-angiotensinogen concentrations and with hyperten-
sive disorders. It is not clear whether this is due to ei-
ther a deleterious effect of a 235Thr-bearing allele or a
protective effect of the 235Met allele. In nonpregnant
subjects, 235Met is associated with lower concentrations
of plasma angiotensinogen, although, in normotensive
pregnant subjects, this pattern was reversed in the pop-
ulation that we studied (Jeunemaitre et al. 1992; Mor-
gan et al. 2000). We have genotyped polymorphisms in
both the 5′ flanking region (corresponding to G217A,
A20C, and A6G) and exon 2 (Thr174Met [C3889T]
and Thr235Met [C4072T]) of AGT, in 96 healthy white
Europeans from Nottingham, United Kingdom, who were
recruited sequentially from a blood-donor clinic (Morgan
et al. 1996). This investigation demonstrated patterns—
both of linkage disequilibrium and of haplotype fre-
quencies—similar to those described for the Utah popu-
lation that Nakajima et al. (2002) studied. We have con-
firmed their observation that a single haplotype carrying
235Met (4072T) accounts for more than half of the genes
in white Europeans (58% in the Nottingham population).
Variants in both the 5′ flanking region and exon 2 were
found only on alleles bearing 235Thr.
We have also screened the 3′ end of the gene—including
the 3′ UTR of exon 5—and the 1,350 bases of flanking
region between exon 5 and the AGT dinucleotide repeat
polymorphism (Kotelevstev et al. 1991) (EMBL Nucle-
otide Sequence Database accession number AJ277498).
We used SSCP analysis and direct sequencing, to char-
acterize six SNPs (table 1). Three polymorphisms iden-
tified in this region have not, to our knowledge, previ-
ously been described; the remaining three correspond to
SNPs 40 (C11535A), 41 (C11608T), and 42 (G12058A),
as observed by Nakajima et al. (2002).
The frequencies of haplotypes that combine these six
SNPs and Thr235Met were estimated by the expecta-
tion-maximization method, by use of Arlequin software.
Strong linkage disequilibrium was observed between all
polymorphisms, and five haplotypes accounted for 91%
of those observed in this study (table 2). Interestingly,
polymorphisms at C11535A and C11608T, which are in
complete linkage disequilibrium with each other, defined
two common haplotypes bearing 235Met. To our knowl-
edge, these are the only SNPs that have, to date, been
described in white Europeans, which split the common
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Table 2
Common Haplotypes Defined by the Met235Thr Polymorphism and Six SNPs at the 3′ End of AGT
HAPLOTYPE
ALLELE AT SNPa
FREQUENCYMet235Thr C11535A C11608A G12058A A12194C C12429T T12822C
1 Met C C G A C T .27
2 Met A A G A C T .27
3 Thr C C G A C C .28
4 Thr C C A C T C .05
5 Thr C C G A C T .04
a Nucleotides are numbered with respect to the transcription start site.
haplotype bearing 235Met; all other variants have been
described in association with the 235Thr allele. C11535A
lies within the 3′ UTR of exon 5; C11608T lies 30 bases
downstream from the 3′ end of exon 5. Whether they
have functional effects on angiotensinogen expression re-
quires further investigation, but it is worth noting that in
vitro experiments have demonstrated that there is en-
hancer activity in this region (Nibu et al. 1994a, 1994b).
Given the interest in the Thr235Met polymorphism as a
marker for hypertensive disorders, we recommend that
genotyping at C11535A or C11608T be included in the
haplotyping profile for angiotensinogen in linkage-dis-
equilibrium studies.
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